FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients

BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is generally associated with a very dismal prognosis. Nevertheless, patients with similar clinicopathological characteristics can have markedly different clinical outcomes. Our aim was the identification of novel molecular determinants influenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tassi, Renata A., Gambino, Angela, Ardighieri, Laura, Bignotti, Eliana, Todeschini, Paola, Romani, Chiara, Zanotti, Laura, Bugatti, Mattia, Borella, Fulvio, Katsaros, Dionyssios, Tognon, Germana, Sartori, Enrico, Odicino, Franco, Romualdi, Chiara, Ravaggi, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889357/
https://www.ncbi.nlm.nih.gov/pubmed/31434988
http://dx.doi.org/10.1038/s41416-019-0553-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889357/
https://www.ncbi.nlm.nih.gov/pubmed/31434988
http://dx.doi.org/10.1038/s41416-019-0553-z

Ejemplares similares